Growth Metrics

Bruker (BRKR) Cost of Revenue (2016 - 2026)

Bruker filings provide 16 years of Cost of Revenue readings, the most recent being $528.0 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 8.57% to $528.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.9 billion, a 8.26% increase, with the full-year FY2025 number at $1.9 billion, up 8.26% from a year prior.
  • Cost of Revenue hit $528.0 million in Q4 2025 for Bruker, up from $481.1 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $528.0 million in Q4 2025 to a low of $276.0 million in Q1 2021.
  • Median Cost of Revenue over the past 5 years was $351.2 million (2022), compared with a mean of $373.0 million.
  • Biggest five-year swings in Cost of Revenue: changed 0.0% in 2022 and later increased 23.85% in 2023.
  • Bruker's Cost of Revenue stood at $341.9 million in 2021, then rose by 0.18% to $342.5 million in 2022, then increased by 23.85% to $424.2 million in 2023, then grew by 14.64% to $486.3 million in 2024, then increased by 8.57% to $528.0 million in 2025.
  • The last three reported values for Cost of Revenue were $528.0 million (Q4 2025), $481.1 million (Q3 2025), and $439.5 million (Q2 2025) per Business Quant data.